Text
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
N-acyl lipids are important, overlooked molecules shaped by diet and gut microbes.
With a strategic loan from the European Investment Bank, the French biotech doubles down on its mission to bring microbiome ecosystem therapies to market for patients battling blood cancers.
Fiber can influence how well bacteria from a fecal microbiota transplant successfully settle and grow in a person’s gut.
Targeting the gut microbiota could help predict, prevent or reduce chemotherapy-related toxicity.
A unique partnership between Yakult and Nature Portfolio to build a global community of microbiome pioneers.
Region-specific microbial transplants may be safer and more effective than standard fecal microbiota transplants.
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.
AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.
